You have read all your free articles, to continue reading subscribe to read the rest of this content.
Elekta recently entered into a partnership with the ESTRO [European Society for Radiotherapy & Oncology] Cancer Foundation (ECF) to contribute – hand in hand with various other partners in academia and industry – to the foundation's mission to ensure that "every patient in Europe will have aAlready a subscriber Login…
Sigrid Therapeutics has announced the publication of a multifaceted, scientific study in the peer-reviewed journal Advanced Healthcare Materials showing that a new approach using mesoporous silica particles (MSPs) can be used to prevent type 2-diabetes and treat obesity. By blocking food enzyme aAlready a subscriber Login You have read all…
A new Norwegian clinical pilot will investigate how women can receive more personalized breast cancer screening. “This ‘one size fits all’ approach does not take into account the different breast cancer risks of individual women. A more personalised screening program might be beneficial forAlready a subscriber Login You have read…
The company has been granted 510(k) clearance by the US Food and Drug Administration (FDA) to market OssDsign Cranial PSI Accessories in the US. The cleared products are a set of 3D-printed, patient specific accessory devices designed to support and expand clinical use of OssDsign’s patient speAlready a subscriber Login…
